Share through
St. Jude Research Logo
About Us
Care & Treatment
Research
Training
Get Involved
Ways to Give
St. Jude Research
WHY ST. JUDE
Back
WHY ST. JUDE
Data and Visualization Tools
Shared Resources
Why St.Jude
Translation Innovation
Scientific Milestones
DEPARTMENTS & LABS
Back
DEPARTMENTS & LABS
Departments
View all departments
Labs
View all labs
Clinical Research
View all clinical researchers
CENTERS & INITIATIVES
Back
CENTERS & INITIATIVES
Comprehensive Cancer Center
Pediatric Translational Neuroscience Initiative
Blue Sky
St. Jude Research Collaboratives
Centers & Initiatives
Global Impact on Infectious Disease
Center of Excellence for Data-Driven Discovery
Center of Excellence for Innate Immunity and Inflammation
Center of Excellence for Pediatric Immuno-Oncology
CAREERS
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Home
Why St. Jude
Shared resources & core facilities
Technology Licensing
Diagnostics
Diagnostics
AML MRD markers (SJ-18-0011)
Association of neuraminidase regulated exocytosis with cancer metastasis (SJ-11-0012)
Blood biomarkers for Alzheimer's disease (SJ-20-0028)
CD19 biomarker for blinatumomab responsiveness in leukemia patients (SJ-20-0006)
CHANGE-seq: a rapid, high-throughput method to define genome-wide activity of CRISPR-Cas genome editors (SJ-18-0041)
Detecting TERT promoter methylation for cancer diagnosis (SJ-16-0015)
Determining CAR T cell effectiveness (SJ-19-0040)
Diagnosing and treating learning or mental disorders with SERCA2 protein and miRNAs (SJ-10-0003, SJ-12-0020)
Genotyping assay to predict CYP3A5 phenotype (SJ-01-0005)
Medulloblastoma subtyping assay (SJ-10-0020)
Methods for detecting COVID Infection, vaccination response and to compare vaccine potency (SJ-22-0003)
New markers for detection of minimal residual disease in acute lymphoblastic leukemia (SJ-11-0025)
Rapid cloning of T cell receptors (SJ-16-0001)
T-ALL biomarker and prediction model (SJ-19-0049)
XAF-1 mutations linked to cancer susceptibility (SJ-15-0016)
For more information
Contact the
Office of Technology Licensing
:
Phone: (901) 595-2342
Fax: (901) 595-3148
OTL Intellectual Properties Newsletters
More Technologies
Antibodies for basic research
Biologics
Drug Discovery Development Tools
Drugs
Other Technologies
Vaccines